MedTrace Logo

TetraSOD® Supplementation and Skeletal Muscle Redox Gene Expression

NCT06822556 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2025-02-12

No results posted yet for this study

Summary

Tetraselmis chuii (TetraSOD) is a marine microalgae that has been reported to improve antioxidant responses in human skeletal muscle cells treated with TetraSOD and to improve recovery from muscle damaging exercise in humans supplemented with TetraSOD. However, the effects of TetraSOD supplementation on human skeletal muscle antioxidant gene expression is less clear.

This study assessed the effect of short-term TetraSOD supplementation on human skeletal muscle antioxidant gene expression in healthy adults.

Conditions

  • Placebo
  • Tetraselmis Chuii

Interventions

DIETARY_SUPPLEMENT

Placebo

14 days of supplementation with 25 mg/day hemicellulose crystalline

DIETARY_SUPPLEMENT

Tetraselmis chuii

14 days of supplementation with 25 mg/day tetraselmis chuii

Sponsors & Collaborators

  • Fitoplancton Marino, S.L.

    collaborator INDUSTRY

  • Loughborough University

    lead OTHER

Principal Investigators

  • Stephen Bailey · Loughborough University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-05
Primary Completion
2022-08-03
Completion
2023-10-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06822556 on ClinicalTrials.gov